554411-22-2

Upstream product

• 554411-21-1 4-(4-methoxy-3-nitro-phenyl)-3,6-dihydro-2H-pyran 
• 1023937-41-8 4-(4-methoxy-3-nitrophenyl)-tetrahydropyran 
• 1023937-40-7 benzyl-[2-methoxy-5-(tetrahydropyran-4-yl)-phenyl]-amine 

Downstream Products

• 554411-23-3 1-benzoyl-3-[2-methoxy-5-(tetrahydro-pyran-4-yl)-phenyl]-thiourea 
• 796062-44-7 1H-imidazole-2-carboxylic acid [2-methoxy-5-(tetrahydropyran-4-yl)phenyl]amide 

Relevant academic research and scientific papers

Carbamic acid esters of benzothiazoles

The present invention relates to a compound of formula I wherein R, X and n are defined hereinabove, and to a pharmaceutically acceptable salt thereof. The compound may be used for the treatment of diseases related to the A2A receptor.

Benzothiazole derivatives

This invention relates to compounds of formula I wherein R1 and R2 are defined herein, or a pharmaceutically acceptable salt thereof. It has been found that the compounds of formula I are adenosine receptor ligands with good affinity to the A2A-receptor and a high selectivity to the A1- and A3 receptors. These compounds are useful, inter alia, in treatment of Alzheimer's disease, depression, Parkinson's disease and ADHD.

Imidazo-benzothiazoles

The invention relates to 2-imidazo-benzothiazoles of general formula wherein R1, R2, R3, R4, R5, R6, R7, R′, R″, X, R′″ and n are defined herein, or a pharmaceutically acceptable salt thereof. It has been found that the compound of formula I are adenosine receptor ligands with good affinity to the A1 and A3 receptors. These compounds have useful pharmaceutical activities.